156 related articles for article (PubMed ID: 17426207)
1. Roles of angiopoietin-1 and angiopoietin-2 on airway microvascular permeability in asthmatic patients.
Kanazawa H; Nomura S; Asai K
Chest; 2007 Apr; 131(4):1035-41. PubMed ID: 17426207
[TBL] [Abstract][Full Text] [Related]
2. Relationship between vascular endothelial growth factor and angiopoietin-2 in asthmatics before and after inhaled beclomethasone therapy.
Nomura S; Kanazawa H; Hirata K; Iwao H; Yoshikawa J
J Asthma; 2005 Mar; 42(2):141-6. PubMed ID: 15871447
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of angiopoietin-2 in induced sputum from smoking asthmatic patients.
Kanazawa H; Asai K; Tochino Y; Kyoh S; Kodama T; Hirata K
Clin Exp Allergy; 2009 Sep; 39(9):1330-7. PubMed ID: 19438587
[TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-2 as a contributing factor of exercise-induced bronchoconstriction in asthmatic patients receiving inhaled corticosteroid therapy.
Kanazawa H; Tochino Y; Asai K
J Allergy Clin Immunol; 2008 Feb; 121(2):390-5. PubMed ID: 18037159
[TBL] [Abstract][Full Text] [Related]
5. A case-control study of bronchial asthma associated with ulcerative colitis: role of airway microvascular permeability.
Kanazawa H; Yoshikawa J
Clin Exp Allergy; 2005 Nov; 35(11):1432-6. PubMed ID: 16297138
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients.
Asai K; Kanazawa H; Kamoi H; Shiraishi S; Hirata K; Yoshikawa J
Clin Exp Allergy; 2003 May; 33(5):595-9. PubMed ID: 12752587
[TBL] [Abstract][Full Text] [Related]
7. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
[TBL] [Abstract][Full Text] [Related]
8. Analysis of vascular endothelial growth factor levels in induced sputum samples from patients with cough variant asthma.
Kanazawa H; Eguchi Y; Nomura N; Yoshikawa J
Ann Allergy Asthma Immunol; 2005 Sep; 95(3):266-71. PubMed ID: 16200818
[TBL] [Abstract][Full Text] [Related]
9. Increased vascular permeability precedes cellular inflammation as asthma control deteriorates.
Khor YH; Teoh AK; Lam SM; Mo DC; Weston S; Reid DW; Walters EH
Clin Exp Allergy; 2009 Nov; 39(11):1659-67. PubMed ID: 19860817
[TBL] [Abstract][Full Text] [Related]
10. VEGF, angiopoietin-1 and -2 in bronchial asthma: new molecular targets in airway angiogenesis and microvascular remodeling.
Kanazawa H
Recent Pat Inflamm Allergy Drug Discov; 2007 Feb; 1(1):1-8. PubMed ID: 19075960
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis and remodeling of airway vasculature in chronic inflammation.
McDonald DM
Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 2):S39-45. PubMed ID: 11734465
[TBL] [Abstract][Full Text] [Related]
12. Role of microvascular permeability on physiologic differences in asthma and eosinophilic bronchitis.
Kanazawa H; Nomura S; Yoshikawa J
Am J Respir Crit Care Med; 2004 May; 169(10):1125-30. PubMed ID: 15044203
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor and cysteinyl leukotrienes in sputum supernatant of patients with asthma.
Papadaki G; Bakakos P; Kostikas K; Hillas G; Tsilogianni Z; Koulouris NG; Papiris S; Loukides S
Respir Med; 2013 Sep; 107(9):1339-45. PubMed ID: 23845883
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of fluticasone and montelukast on allergen-induced asthma.
Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma.
Chetta A; Zanini A; Foresi A; D'Ippolito R; Tipa A; Castagnaro A; Baraldo S; Neri M; Saetta M; Olivieri D
Clin Exp Allergy; 2005 Nov; 35(11):1437-42. PubMed ID: 16297139
[TBL] [Abstract][Full Text] [Related]
16. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast.
Jayaram L; Pizzichini E; Lemière C; Man SF; Cartier A; Hargreave FE; Pizzichini MM
Thorax; 2005 Feb; 60(2):100-5. PubMed ID: 15681495
[TBL] [Abstract][Full Text] [Related]
17. Asthma hospitalization risk and costs for patients treated with fluticasone propionate vs montelukast.
Orsini L; Limpa-Amara S; Crown WH; Stanford RH; Kamal K
Ann Allergy Asthma Immunol; 2004 May; 92(5):523-9. PubMed ID: 15191020
[TBL] [Abstract][Full Text] [Related]
18. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
Fritscher LG; Rodrigues MT; Zamel N; Chapman KR
Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684
[TBL] [Abstract][Full Text] [Related]
19. [Effects of leukotriene receptor antagonists on vascular endothelial growth factor and its receptors in a sensitized rat model].
Yang HS; Wang L; Yang W; Guan JT; Ma JY; Su Y
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Mar; 32(3):177-81. PubMed ID: 19575935
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of angiopoietins 1 and 2 in sputum supernatant in severe refractory asthma.
Tseliou E; Bakakos P; Kostikas K; Hillas G; Mantzouranis K; Emmanouil P; Simoes D; Alchanatis M; Papiris S; Loukides S
Allergy; 2012 Mar; 67(3):396-402. PubMed ID: 22229541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
